One drug, many rare diseases
CNBC Advisory Board member Dr. Anna Greka has built her career on finding connections between different rare diseases. Greka, a...
HEALTH & FITNESS
Micron drops despite ‘a great quarter.’ Why Cramer is sticking with the stock
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
AI is inside the healthcare billing system. It may be costing patients
Picture Alliance | Picture Alliance | Getty ImagesAI is moving deeper into an already expensive and administratively complex U.S. healthcare...
Grindr expands beyond dating with $250 million PurposeMed acquisition
Grindr announced on Wednesday that it is expanding further into health care with the acquisition of PurposeMed, the parent company...
Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial
Eli Lilly on Wednesday said its experimental combination regimen showed greater weight loss than a high dose of its top-selling...
Novo’s Wegovy pill improves weight loss after switch from injections
People who switched from obesity injections to Novo's new Wegovy pill continued to lose weight after three months, according to...
Trump moves to block $810 million in funding through pocket rescission
The U.S. Capitol is seen on March 16, 2026, in Washington.Anna Moneymaker | Getty ImagesThe White House on Friday evening...
NIH cuts delayed a cancer trial. Patients lost time they didn’t have
In 2025, John Paul Macri's learned he had fast-growing, aggressive type of brain cancer.Nick and Katie MacriCNBC Cures is proudly...
Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time...
Novo Nordisk CEO on rebuilding investor trust after backlash
Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in Copenhagen, Denmark,...
Trump administration removes around 760,000 Obamacare enrollments
The Centers for Medicare and Medicaid Services said on Tuesday it canceled roughly 315,000 Affordable Care Act marketplace enrollments covering...
Eli Lilly CEO David Ricks discusses GLP-1s and Medicare coverage
Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since Medicare coverage...
Lilly is ramping up future manufacturing for Foundayo obesity pill
Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking the drugmaker's...
Mitch McConnell returns to Senate after three-month health absence
Sen. Mitch McConnell, R-Ky., returned to the Capitol on Monday after a three-month absence following a fall that left him...
Athletes with autism take center court at the US Open
The USTA unveils the largest single investment in U.S. Open history.USTACNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease,...
Novo Nordisk rebrands to ‘Novo’ under CEO Mike Doustdar
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark,...
Record U.S. cyclosporiasis outbreak is over, CDC says
People shop at a Manhattan grocery store on August 13, 2026, in New York City. Spencer Platt | Getty ImagesThe...
Here’s a rapid-fire update on our 33-stock portfolio, including Cramer’s 6 favorites to buy
Jim's current faves include three tech names and a bank stock. Source link
Rare disease is taking his sight. Access to a treatment is hard to get
Judy and Courtney Stecker with their sons, Read (left) and Wheeler (right).Judy and Courtney SteckerCNBC Cures is proudly underwritten by...
Jim Cramer says investors are too focused on AI stocks. Here’s where he says to look instead
CNBC's Jim Cramer said Tuesday that investors need to expand their horizons beyond the artificial intelligence trade."There's more to life...
